The octadecaneuropeptide-induced response of corticotropin-releasing hormone messenger RNA levels is mediated by GABA(A) receptors and modulated by endogenous steroids

Neuroscience

Volumn 85, Issue 2, 1998, Pages 557-567

  Givalois, L ^b   Grinevich, V ^a   Li, S ^a   Garcia De Yebenes, E ^a   Pelletier, G ^a  

^a LAVAL UNIVERSITY   (Canada)

^b CNRS   (France)

Author keywords

Adrenal and sexual steroids; CRH mRNA; GABA(A) receptor; Hypothalamo pituitary adrenocortical axis; Neurosteroids; Octadecaneuropeptide

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; BENZODIAZEPINE RECEPTOR; CORTICOTROPIN RELEASING FACTOR; FINASTERIDE; MUSCIMOL; NEUROPEPTIDE; PICROTOXIN; SEX HORMONE;

ADRENALECTOMY; ANIMAL EXPERIMENT; ARTICLE; CASTRATION; ENZYME ACTIVITY; GENE EXPRESSION; HYPOPHYSIS ADRENAL SYSTEM; IN SITU HYBRIDIZATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; SIGNAL TRANSDUCTION; STEROID RELEASE;

ADRENALECTOMY; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; DIAZEPAM BINDING INHIBITOR; INJECTIONS, INTRAVENTRICULAR; MALE; NEUROPEPTIDES; ORCHIECTOMY; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; RNA, MESSENGER; STEROIDS;

EID: 0032495805     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00650-7     Document Type: Article

References (58)

1. Alho H., Bovolin P., Slobodyansky E. Diazepam binding inhibitor (DBI) processing: immunohistochemical studies in the rat brain. Neurochem. Res. 15:1990;209-216.
2. Alho H., Costa E., Ferrero P., Fujimoto M., Cosenza-Murphy D., Guidotti A. Diazepam binding inhibitor: a neuropeptide located in selected neuronal populations of rat brain. Science. 229:1985;179-182.
3. Assenmacher I., Barbanel G., Gaillet S., Givalois L., Ixart G., Malaval F., Mekaouche M., Siaud P., Szafarczyk A. Central regulation of ACTH release in stress. Ann. N.Y. Acad. Sci. 771:1995;41-54.
4. Bloom F. E., Battenber E., Rivier J., Vale W. Corticotropin-releasing factor (CRF) immunoreactive neurones and fibers in rat hypothalamus. Regul. Pept. 4:1982;43-48.
5. Calogero A. E., Galluci W. T., Chrousos G. P., Gold P. W. Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro. Brain Res. 463:1988;28-36.
6. Costa E., Ahlo H., Santi R., Ferrero P. and Guidotti A. (1986) Cotransmission of GABAergic synapses. In Progress in Brain Research (eds Hokfelt T., Fuxe K. and Pernow B.), Vol. 68, pp. 343-355. Elsevier, Amsterdam.
7. Fenelon V. S., Herbison A. E. Characterisation of GABA(A) receptor gamma subunit expression by magnocellular neurones in rat hypothalamus. Molec. Brain Res. 34:1995;45-56.
8. Ferrarese C., Appollonio I., Bianchi G., Frigo M., Marzorati C., Pecora N., Perego M., Pierpaoli C., Frattola L. Benzodiazepine receptors and diazepam binding inhibitor: a possible link between stress, anxiety and the immune system. Psychoneuroendocrinology. 18:1993;3-22.
9. Ferrarese C., Mennini T., Pecora N., Gobbi M., Appollonio I., Bernasconi P., Frigo M., Regondi C., Pierpaoli C., Frattola L. Acute noise stress in rats increases the levels of diazepam binding inhibitor (DBI) in hippocampus and adrenal gland. Psychopharmacology. 103:1991;339-342.
10. Ferrero P., Guidotti A., Conti-Tronconi B. A brain octadecaneuropeptide generated by tryptic digestion of DBI (diazepam binding inhibitor) functions as a proconflict ligand of benzodiazepine recognition sites. Neuropharmacology. 23:1984;1359-1362.
11. Ferrero P., Santi M. R., Conti-Tronconi B., Costa E., Guidotti A. Study of an octadecaneuropeptide derived from diazepam binding inhibitor (DBI): Biological activity and presence in rat brain. Proc. natn. Acad. Sci. U.S.A. 83:1986;827-831.
12. 2+ in rat astrocytes is not mediated through classical benzodiazepine receptors. Eur. J. Pharmac. 322:1997;275-281.
13. - ionophore by steroids in rat brain. Eur. J. Pharmac. 36:1987;419-423.
14. Givalois L., Li S., Pelletier G. Age-related decrease in the hypothalamic CRH mRNA expression is reduced by dehydroepiandrosterone (DHEA) treatment in male and female rats. Molec. Brain Res. 48:1997;107-114.
15. Guidotti A., Forchetti C. M., Corda M. G., Konkel D., Bennett C. D., Costa E. Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc. natn. Acad. Sci. U.S.A. 80:1983;3531-3535.
16. Hamill O. P., Bormann J. P., Sakmann B. Activation of multiple-conductance state chloride channels in spinal neurones by glycine and GABA. Nature. 308:1983;803-808.
17. Hillhouse E. W., Milton N. G. Effect of noradrenaline and gamma-aminobutyric acid on the secretion of corticotropin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro. J. Endocr. 122:1989;719-723.
18. Imaki T., Nahan J. L., Rivier C., Sawchenko P. E., Vale W. Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress. J. Neurosci. 11:1991;583-599.
19. Imaki T., Xiaoquan W., Shibasaki T., Harada S., Chikada N., Takahashi C., Naruse M., Demura H. Chlordiazepoxide attenuates stress-induced activation of neurons, corticotropin-releasing factor (CRF) gene transcription and CRF biosynthesis in the paraventricular nucleus (PVN). Molec. Brain Res. 32:1995;261-270.
20. Kavaliers M., Hirst M. An octadecaneuropeptide (ODN) derived from diazepam binding inhibitor increases aggressive interactions in mice. Brain Res. 383:1986;343-349.
21. Lamacz M., Tonon M. C., Smihrouet F., Patte C., Gasque P., Fontaine M., Vaudry H. The endogenous benzodiazepine receptor-ligand ODN increases cytosolic calcium in cultured rat astrocytes. Molec. Brain Res. 37:1996;290-296.
22. A receptor function. Trends pharmac. Sci. 16:1995;295-303.
23. A receptors to neurosteroids. J. Neurochem. 57:1991;1818-1821.
24. Li S., Givalois L., Pelletier G. Involvement of neurosteroids in the effect of the endogenous benzodiazepine receptor ligand octadecaneuropeptide (ODN) on gonadotropin-releasing hormone gene expression in rat brain. J. Neuroendocr. 9:1997;229-233.
25. Li S., Pelletier G. Inhibitory effect of the potential endogenous benzodiazepine receptor ligand, octadecaneuropeptide (ODN), on gonadotropin-releasing hormone gene expression in the male rat brain. NeuroReport. 6:1995;1354-1356.
26. Li S., Pelletier G. Further studies on the mechanism of action of the endogenous benzodiazepine receptor ligand octadecaneuropeptide on gonadotropin-releasing hormone gene expression in the rat brain. Neuroendocrinology. 64:1996;79-84.
27. Liposits Z. Ultrastructural immunocytochemistry of the hypothalamic corticotropin releasing hormone synthesizing system. Prog. Histochem. Cytochem. 21:1990;1-98.
28. Louiset E., Vaudry H. and Cazin L. (1993) Allosteric modulation of the GABA-induced chloride current in frog melanotrophs. In The Melanotropic Peptides (eds Vaudry H. and Eberle A. N.), pp. 565-566. N.Y. Acad. Sci., New York.
29. M'Iguez I., Aldegunde M. A. Effect of gamma-aminobutyric acid on corticosterone secretion: involvement of the noradrenergic system. Life Sci. 46:1990;875-880.
30. A receptor channels. Cell. Physiol. Biochem. 3:1993;352-373.
31. A receptor channels. A. Rev. Neurosci. 17:1994;569-602.
32. A receptor. Brain Res. 526:1990;143-146.
33. Majewska M. D., Harrison N. L., Schwartz R. D., Barker J. L., Paul S. M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 232:1986;1004-1007.
34. Malagon M., Vaudry H., Stuen F. V., Pelletier G., Navarro F. G., Tonon M. C. Ontogeny of diazepam-binding inhibitor related peptides (endozepines) in the rat brain. Neuroscience. 57:1993;777-786.
35. Meister B., Hökfelt T., Geffard M., Oertel W. Glutamic acid decarboxylase- and γ-aminobutyric acid-like immunoreactivity in corticotropin-releasing factor-containing parvocellular neurons of the hypothalamic paraventricular nucleus. Neuroendocrinology. 48:1988;516-526.
36. Orchinik M., Weiland N. G., McEwen B. S. Adrenalectomy selectively regulates GABAA receptor subunit expression in the hippocampus. Mol. Cell Neurosci. 5:1994;451-458.
37. A receptor subunit mRNA levels in rat hippocampus. Molec. Brain Res. 34:1995;29-37.
38. Papadopoulos V. Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function. Endocr. Rev. 14:1993;222-240.
39. Patte C., Vaudry H., Desrues L., Gandolfo P., Strijdveen I., Lamacz M., Tonon M. C. The endozepine ODN stimulates polyphosphoinositide metabolism in rat astrocytes. Fedn Eur. biochem. Socs Lett. 362:1995;106-110.
40. Paul S. M., Purdy R. Neuroactive steroids. Fedn Am. Socs exp. Biol. J. 6:1992;2311-2322.
41. Plotsky P. M., Otto S., Sutton S. Neurotransmitter modulation of corticotropin-releasing factor secretion into the hypophysial portal circulation. Life Sci. 41:1987;1311-1317.
42. A receptor subunit composition? Receptors Channels. 1:1993;135-142.
43. Rivest S., Laflamme N. Neuronal activity and neuropeptide gene transcription in the brains of immune-challenged rats. J. Neuroendocr. 7:1995;501-525.
44. Rivier C., Plotsky P. M. Mediation by corticotropin-releasing factor (CRF) or adenohypophyseal hormone secretion. A. Rev. Physiol. 48:1986;475-494.
45. Roy A., Pickar D., Gold P., Barbaccia M., Guidotti A., Costa E., Linnoila M. Diazepam-binding inhibitor and corticotropin-releasing hormone in cerebrospinal fluid. Acta Psychiat. Scand. 80:1989;287-291.
46. 35S]TBPS binding to gamma-aminobutyric acidA recptors in rat brain. J. Pharmac. Exp. Ther. 262:1992;801-808.
47. Sawchenko P. E. Adrenalectomy-induced enhancement of CRF and vasopressin immunoreactivity in parvocellular neurosecretory neurons: anatomic, peptide, and steroid specificity. J. Neurosci. 7:1987;1093-1106.
48. Sawchenko P. E., Swanson L. W. Localization, colocalization and plasticity of corticotropin-releasing factor immunoreactivity in rat brain. Fedn Proc. 44:1985;221-227.
49. Sawchenko P. E. and Swanson L. W. (1990) Organization of CRF immunoreactive cells and fibers in the rat brain: immunohistochemical studies. In Corticotropin-Releasing Factor: Basic and Clinical Studies of a Neuropeptide (eds DeSouza E. B. and Nemeroff C. B.), pp. 29-51. CRC Uniscience, Boca Raton.
50. - ion channels modulated by multiple drug-binding sites. Trends Pharmac. Sci. 13:1992;446-450.
51. Slobodyansky E., Guidotti A., Wambebe C., Berkovich A., Costa E. Isolation and characterization of a rat brain triakontatetraneuropeptide, a posttranslational product of diazepam binding inhibitor: specific action at the Ro5-4864 recognition site. J. Neurochem. 53:1989;1276-1284.
52. Spinedi E., Giacomini M., Jacquier M. C., Gaillard R. C. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action. Neuroendocrinology. 53:1991;160-170.
53. Swanson L. W., Sawchenko P. E., Rivier J., Vale W. Organization of ovine corticotropin releasing factor immunoreactive cells and fibers in the rat brain; an immunohistochemical study. Neuroendocrinology. 36:1983;165-186.
54. Tong Y., Toranzo D., Pelletier G. Localization of diazepam-binding inhibitor (DBI) mRNA in the rat brain by high resolution in situ hybridization. Neuropeptides. 20:1991;33-40.
55. Tonon M. C., Adjeroud S., Lamacz M., Louiset E., Danger J. M., Desrues L., Cazin L., Nicolas P., Vaudry H. Central-type benzodiazepines and the octadecaneuropeptide modulate the effects of GABA on the release of α-melanocyte-stimulating hormone from frog neurointermediate lobe in vitro. Neuroscience. 31:1989;485-493.
56. Tonon M. C., Desy L., Nicolas P., Vaudry H., Pelletier G. Immunocytochemical localization of the endogenous benzodiazepine ligand octadecaneuropeptide (ODN) in the rat brain. Neuropeptides. 15:1990;17-24.
57. A receptor are regulated by progesterone in subfields of the hippocampus. Molec. Brain Res. 32:1995;271-278.
58. Zhu W. J., Wang J. F., Krueger K. E., Vicini S. δ subunit inhibits neurosteroid modulation of GABAA receptors. J. Neurosci. 16:1996;6648-6656.